{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:05:56Z","timestamp":1789376756577,"version":"build-2803163510"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Pharmacogenomics (PGx) is a key component of precision medicine, linking genetic variation to drug response, effectiveness, and toxicity. However, Middle Eastern and North African (MENA) populations remain underrepresented in global genomic databases, limiting PGx\u2019s clinical utility in these regions. This review examines the current state of pharmacogenomics in the United Arab Emirates (UAE), focusing on genomic initiatives, population-specific variation, and challenges in clinical implementation. National genomic programs, including the Emirati Genome Program, have begun to address this gap by generating ancestry-specific data. Studies of UAE populations reveal clinically relevant variation in pharmacogenes that affect commonly used drugs such as warfarin, clopidogrel, and statins, as well as rare and understudied variants with potential functional impact. Additional evidence highlights the role of HLA diversity and genetic factors in metabolic and inflammatory conditions. Despite these advances, implementation remains constrained by gaps in healthcare professional education, infrastructure, regulatory frameworks, and public awareness. The UAE is well-positioned to advance PGx through targeted clinical integration, the development of local reference systems, and strengthened policy support. These efforts are essential to enable effective, population-specific precision medicine in the region.<\/jats:p>","DOI":"10.3389\/fphar.2026.1902530","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T07:44:01Z","timestamp":1788767041000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacogenomics in the United Arab Emirates: advances in population genomics and challenges in clinical implementation"],"prefix":"10.3389","volume":"17","author":[{"given":"Abderraouf","family":"Haitamar","sequence":"first","affiliation":[{"name":"Research Institute for Medical and Health Science, University of Sharjah","place":["Sharjah, United Arab Emirates"]},{"name":"Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Eiyad Abu-Nada","sequence":"additional","affiliation":[{"name":"Research Institute for Medical and Health Science, University of Sharjah","place":["Sharjah, United Arab Emirates"]},{"name":"Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Wed Eladham","sequence":"additional","affiliation":[{"name":"Research Institute for Medical and Health Science, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Mdkhana","sequence":"additional","affiliation":[{"name":"Research Institute for Medical and Health Science, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjes","family":"Saheb Sharif-Askari","sequence":"additional","affiliation":[{"name":"Research Institute for Medical and Health Science, University of Sharjah","place":["Sharjah, United Arab Emirates"]},{"name":"Department of Clinical Sciences, College of Medicine, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabih","family":"Halwani","sequence":"additional","affiliation":[{"name":"Research Institute for Medical and Health Science, University of Sharjah","place":["Sharjah, United Arab Emirates"]},{"name":"Prince Fahad Bin Sultan chair for Biomedical Research, University of Tabuk","place":["Tabuk, Saudi Arabia"]},{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]},{"name":"Health and Wellbeing, NEOM","place":["Tabuk, Saudi Arabia"]},{"name":"King Saud University Celiac Disease Research Chair, department of Pediatric, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Saheb Sharif-Askari","sequence":"additional","affiliation":[{"name":"Research Institute for Medical and Health Science, University of Sharjah","place":["Sharjah, United Arab Emirates"]},{"name":"Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e70300","DOI":"10.1111\/cts.70300","article-title":"Knowledge and views of patients with cardiovascular disease toward pharmacogenomics in the United Arab Emirates","volume":"18","author":"Abbas","year":"","journal-title":"Clin. Transl. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40246-025-00896-6","article-title":"Strategic insights into pharmacogenomics coverage: a theory-informed SWOT analysis of UAE insurance stakeholders\u2019 perspectives","volume":"20","author":"Abbas","year":"","journal-title":"Hum. Genomics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s10038-017-0402-y","article-title":"A 1000 Arab genome project to study the Emirati population","volume":"63","author":"Al-Ali","year":"2018","journal-title":"J. Hum. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1017\/s0021932097004914","article-title":"Consanguineous marriages in the United Arab Emirates","volume":"29","author":"al-Gazali","year":"1997","journal-title":"J. Biosoc. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/PGPM.S187350","article-title":"VKORC1 variants as significant predictors of warfarin dose in Emiratis","volume":"12","author":"Al-Mahayri","year":"2019","journal-title":"Pharmgenomics Pers. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40246-022-00417-9","article-title":"Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates","volume":"16","author":"Al-Mahayri","year":"2022","journal-title":"Hum. Genomics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"29215","DOI":"10.1038\/s41598-025-14577-w","article-title":"Multi-omics analysis of bariatric surgery\u2019s impact on type 2 diabetes and prediabetes","volume":"15","author":"Almazrouei","year":"2025","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/0115701611283841231227064343","article-title":"Utilizing pharmacogenomic data for a safer use of statins among the Emirati population","volume":"22","author":"Alqasrawi","year":"2024","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fphar.2025.1656520","article-title":"A multi-centre observational cohort study on pharmacogenomic predictors of rosuvastatin discontinuation in a multiethnic population","volume":"16","author":"Alqasrawi","year":"","journal-title":"Front. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40246-025-00753-6","article-title":"Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE\u2019s multiethnic population","volume":"19","author":"Alqasrawi","year":"","journal-title":"Hum. Genomics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"14725","DOI":"10.1038\/s41598-019-50876-9","article-title":"Introducing the first whole genomes of nationals from the United Arab Emirates","volume":"9","author":"AlSafar","year":"2019","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fphar.2025.1655617","article-title":"Pharmacogenomic biomarkers of ACE inhibitor\u2013induced cough in a multi-ethnic UAE cohort","volume":"16","author":"Altoum","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.humimm.2019.04.013","article-title":"HLA genetic study from United Arab Emirates (UAE), Abu Dhabi","volume":"80","author":"Arnaiz-Villena","year":"2019","journal-title":"Hum. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000530619","article-title":"Population genome programs across the Middle East and North Africa: successes, challenges, and future directions","volume":"8","author":"Ateia","year":"2023","journal-title":"Biomed. Hub."},{"key":"B15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.1084564","article-title":"The human genome Project: lessons from large-scale biology","volume":"300","author":"Collins","year":"2003","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"100213","DOI":"10.1016\/j.metop.2022.100213","article-title":"Monogenic diabetes variants in Emirati women with gestational diabetes are associated with risk of non-autoimmune diabetes within 5 years after pregnancy","volume":"16","author":"Daggag","year":"2022","journal-title":"Metab. Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"660428","DOI":"10.3389\/fgene.2021.660428","article-title":"A population-specific major allele reference genome from the United Arab Emirates population","volume":"12","author":"Daw Elbait","year":"2021","journal-title":"Front. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJMoa0809329","article-title":"Estimation of the warfarin dose with clinical and pharmacogenetic data","volume":"360","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/humu.22530","article-title":"Genomics into healthcare: the 5th pan Arab human genetics conference and 2013 golden helix symposium","volume":"35","author":"Fortina","year":"2014","journal-title":"Hum. Mutat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12913-024-12086-6","article-title":"Enhancing the understanding of safety and the quality of patient care among medical and health sciences students in interprofessional climate: an interventional study","volume":"25","author":"Guraya","year":"2025","journal-title":"BMC Health Serv. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e81894","DOI":"10.7759\/cureus.81894","article-title":"Willingness to participate in medical research among adults in the United Arab Emirates (UAE): a cross-sectional Study","volume":"17","author":"Hajjar","year":"2025","journal-title":"Cureus"},{"key":"B22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12687-011-0072-y","article-title":"Consanguineous marriages","volume":"3","author":"Hamamy","year":"2012","journal-title":"J. Community Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nature03001","article-title":"Finishing the euchromatic sequence of the human genome","volume":"431","author":"International Human Genome Sequencing","year":"2004","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"100508","DOI":"10.1016\/j.rcsop.2024.100508","article-title":"Empowering precision medicine: insights from a national survey on pharmacogenomics knowledge, attitudes, and perceptions among community pharmacists in the UAE","volume":"16","author":"Jairoun","year":"2024","journal-title":"Explor. Res. Clin. Soc. Pharm."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-020525-030036","article-title":"Pangenomic initiatives in the Middle East","volume":"27","author":"Jamalalail","year":"2026","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40246-023-00568-3","article-title":"The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati population","volume":"18","author":"Khasawneh","year":"2024","journal-title":"Hum. Genomics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1038\/s41598-024-53986-1","article-title":"Investigating the genetic makeup of the major histocompatibility complex (MHC) in the United Arab Emirates population through next-generation sequencing","volume":"14","author":"Marzouka","year":"2024","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41576-022-00572-8","article-title":"Pharmacogenomics: current status and future perspectives","volume":"24","author":"Pirmohamed","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/jpm10040216","article-title":"Knowledge, attitudes, and perceived barriers toward genetic testing and pharmacogenomics among healthcare workers in the United Arab Emirates: a cross-sectional Study","volume":"10","author":"Rahma","year":"","journal-title":"J. Personalized Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/jpm10040191","article-title":"Knowledge and attitudes of medical and health science students in the United Arab Emirates toward genomic medicine and pharmacogenomics: a cross-sectional Study","volume":"10","author":"Rahma","year":"","journal-title":"J. Personalized Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/jpm10030134","article-title":"Genomics and pharmacogenomics knowledge, attitude and practice of pharmacists working in United Arab Emirates: findings from Focus Group Discussions\u2014A qualitative Study","volume":"10","author":"Rahma","year":"","journal-title":"J. Personalized Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000513753","article-title":"Stakeholders\u2019 interest and attitudes toward genomic medicine and pharmacogenomics implementation in the United Arab Emirates: a qualitative Study","volume":"24","author":"Rahma","year":"","journal-title":"Public Health Genomics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/omi.2021.0029","article-title":"Mapping the educational environment of genomics and pharmacogenomics in the United Arab Emirates: a mixed-methods triangulated design","volume":"25","author":"Rahma","year":"","journal-title":"Omics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40246-021-00361-0","article-title":"Development of the pharmacogenomics and genomics literacy framework for pharmacists","volume":"15","author":"Rahma","year":"","journal-title":"Hum. Genomics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40246-023-00509-0","article-title":"Knowledge, attitudes, and perceptions of the multi-ethnic population of the United Arab Emirates on genomic medicine and genetic testing","volume":"17","author":"Rahma","year":"2023","journal-title":"Hum. Genomics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40246-024-00574-z","article-title":"Investigation of community pharmacists\u2019 knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice","volume":"18","author":"Ramadan","year":"2024","journal-title":"Hum. Genomics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"117350","DOI":"10.1016\/j.bcp.2025.117350","article-title":"Evaluation of the functional impact of rare CYP2C19 missense variants identified in understudied populations: an Integrated in silico and in vitro analysis","volume":"242","author":"Saleous","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1326776","DOI":"10.3389\/fphar.2024.1326776","article-title":"From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice","volume":"15","author":"Shubbar","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","article-title":"Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program","volume":"590","author":"Taliun","year":"2021","journal-title":"Nature"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1902530\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:40:28Z","timestamp":1789375228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1902530\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":41,"alternative-id":["10.3389\/fphar.2026.1902530"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1902530","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"1902530"}}